AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AIM ImmunoTech Inc. Director's Dealing 2014

Jun 11, 2014

Director's Dealing

Opens in your device viewer

Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2014-06-06

Reporting Person: Springate Wayne S. (VP of Operations)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-06	Options to buy Common Stock	$0.36	J	50000	Acquired	2024-06-06	Common Stock (50000)	Direct

F1: Stock Options issued as a result of a Board resolution to grant 50,000 shares.